Home LiteratureArticle Details
PMID: 7047044 Published · ppublish English Journal Article

Renal handling of captopril: effect of probenecid.

Clinical pharmacology and therapeutics ·Vol. 32 ·No. 2 ·1982-08-00 ·Pages 182-9

Sinhvi SM, Duchin KL, Willard DA, McKinstry DN, Migdalof BH

Abstract

14C-Captopril was given intravenously to four normal subjects in a 4-mg priming dose followed by constant intravenous infusion of 1.7 mg/hr for 3.5 hr with and without concomitant probenecid. Steady-state levels of unchanged captopril were obtained between 1.5 and 3.5 hr. In the presence of probenecid, the average steady-state blood levels of total radioactivity were higher (36%) than on captopril alone. Unchanged captopril levels were slightly higher (14%) in the presence of probenecid. Kinetic evaluations were carried out exclusively on data for unchanged captopril. The average total body clearance (ClT) and renal clearance (ClR) of captopril in the absence of probenecid were 775 and 388 ml/kg/hr. The corresponding values for captopril with probenecid (631 and 217 ml/kg/hr) were lower. The average ratio of ClR to ClT for captopril alone was 0.50 and fell to 0.35 in the presence of probenecid. When captopril alone was given, a minimum of 78% of the renal excretion of captopril during steady-state could be attributed to net tubular secretion, but when captopril was given with probenecid, net tubular secretion was only 56%. The volume of distribution of captopril during steady state was not altered by probenecid. For the first 3.5 hr, cumulative renal excretion of total radioactivity with and without probenecid was 55% and 60%, but cumulative excretion of unchanged captopril was higher after captopril alone (36% of dose) than after the combination (21% of dose).

MeSH Terms
Adult Captopril/metabolism,urine Glomerular Filtration Rate/drug effects Humans Kidney/drug effects,metabolism Kinetics Male Probenecid/pharmacology Proline/analogs & derivatives
Chemicals
Proline Captopril Probenecid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sinhvi S M
Duchin K L
Willard D A
McKinstry D N
Migdalof B H
Article Info
Journal
Clinical pharmacology and therapeutics
Abbr.
Clin Pharmacol Ther
ISSN
0009-9236
Published
1982-08-00
Pages
182-9
Language
English
Region
United States
NLM ID
0372741
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com